Evidence map›Paper›PMID 40827590›Full record

ArticleThe Cochrane database of systematic reviews2025

Botulinum toxin for provoked vestibulodynia.

Saehyeon Kim, John J Paliakkara, Julia Schmutz, Norio Watanabe

Abstract readClinical Trial Protocol
In one paragraph

Article in The Cochrane database of systematic reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Saehyeon KimDepartment of Family Medicine, SUNY Upstate Medical University, Syracuse, NY, USA.ORCID 0000-0003-4028-3837
John J PaliakkaraDepartment of Family Medicine, SUNY Upstate Medical University, Syracuse, NY, USA.ORCID 0009-0008-4309-2298
Julia SchmutzDepartment of Family Medicine, SUNY Upstate Medical University, Syracuse, NY, USA.
Norio WatanabeDepartment of Psychiatry, Soseikai General Hospital, Kyoto, Japan.ORCID 0000-0001-9768-993X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis is a protocol for a Cochrane Review (intervention). The objectives are as follows: The primary objective is to examine the efficacy of botulinum toxin therapy in the treatment of provoked vestibulodynia (PVD) compared with placebo or no treatment. The secondary objectives are to investigate the dose effect of botulinum toxin and the complication rates associated with botulinum toxin.

Indexed as

Botulinum ToxinsBotulinum Toxins, Type ANeuromuscular AgentsVulvodyniaFemaleHumansRandomized Controlled Trials as TopicBotulinum ToxinsBotulinum Toxins, Type ANeuromuscular Agents

Identifiers

PMID40827590
PMCPMC12362613

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.